Joel Lewis, President and CEO: Galectin Therapeutics GALT Sell · Filed 24/12/26

Trade details

Type: Insider sale
Amount: $49,840
Shares · price: 56,000 sh · $0.89 a share
Held after: 897,012 sh
Stock: Galectin Therapeutics GALT
Person: Joel LewisPresident and CEO
Trade date: 24/12/23
Filed: 24/12/26
Days to filing: 3 days

Sold 5.9% of holdings

Share of holding sold: 5.9%

Galectin Therapeutics trades, last 26 weeks

What else happened in Galectin Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/23~25/01/22

Joel Lewis's recent trades

Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$135K
37,698 sh
$135K
Filed 01/06
Traded 01/06
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$108.4K
27,731 sh
$108.4K
Filed 01/06
Traded 01/05
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$78K
18,571 sh
$78K
Filed 01/06
Traded 01/02
Joel LewisPresident and CEO
Planned sale10b5-1 planGalectin Therapeutics
Planned sale10b5-1 plan
Galectin Therapeutics
GALT
$352.8K
84,000 sh
$352.8K
Filed 01/02
Traded 01/02
Joel LewisPresident and CEO
Sell10b5-1 planGalectin Therapeutics
Sell10b5-1 plan
Galectin Therapeutics
GALT
$55.3K
7,829 sh
$55.3K
Filed 25/12/19
Traded 25/12/17

Joel Lewis, CEO — sold $49.8K of Galectin Therapeutics GALT · 5.9% of holdings · 10b5-1 plan | Whalegun